Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Survival after brain metastases from breast cancer in the trastuzumab era.

Literature DB >> 15774813

Survival after brain metastases from breast cancer in the trastuzumab era.

David G Kirsch, Carlos J Ledezma, Christina S Mathews, Atul K Bhan, Marek Ancukiewicz, Fred H Hochberg, Jay S Loeffler.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 15774813 DOI： 10.1200/JCO.2005.05.249

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

40 in total

1. Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies.

Authors: Javier Puente Vázquez; Sara López-Tarruella Cobo; José A García-Sáenz; Antonio Casado Herráez; Fernando Moreno Antón; Teresa Sampedro Gimeno; Coralia Bueno Muiño; Enrique Grande Pulido; Miguel Martín Jiménez; Eduardo Díaz-Rubio
Journal: Clin Transl Oncol Date: 2006-01 Impact factor: 3.405

Review 2. Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Authors: Ankit I Mehta; Adam M Brufsky; John H Sampson
Journal: Cancer Treat Rev Date: 2012-06-22 Impact factor: 12.111

Review 3. Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?

Authors: Eleonora Teplinsky; Francisco J Esteva
Journal: Curr Oncol Rep Date: 2015-10 Impact factor: 5.075

4. Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.

Authors: Romuald Le Scodan; Christophe Massard; Ludivine Jouanneau; Florence Coussy; Maya Gutierrez; Youlia Kirova; Florence Lerebours; Alain Labib; Emmanuelle Mouret-Fourme
Journal: J Neurooncol Date: 2011-07-07 Impact factor: 4.130

5. HER2-positive breast cancer brain metastases: multiple responses to systemic chemotherapy and trastuzumab--a case report.

Authors: D N Church; A Bahl; A Jones; C G A Price
Journal: J Neurooncol Date: 2006-07-05 Impact factor: 4.130

6. Clinical significance of KISS1 protein expression for brain invasion and metastasis.

Authors: Ilya V Ulasov; Natalya V Kaverina; Peter Pytel; Bart Thaci; Feifei Liu; Douglas R Hurst; Danny R Welch; Husein A Sattar; Olufunmilayo I Olopade; Anatoly Y Baryshnikov; Zaira G Kadagidze; Maciej S Lesniak
Journal: Cancer Date: 2011-09-16 Impact factor: 6.860

Survival after brain metastases from breast cancer in the trastuzumab era.

1. Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies.

Review 2. Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Review 3. Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?

4. Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.

5. HER2-positive breast cancer brain metastases: multiple responses to systemic chemotherapy and trastuzumab--a case report.

6. Clinical significance of KISS1 protein expression for brain invasion and metastasis.

Review 7. CNS complications of breast cancer: current and emerging treatment options.

Review 8. Systemic therapy of brain metastases.

9. Have changes in systemic treatment improved survival in patients with breast cancer metastatic to the brain?

Review 10. Prognostic indices for brain metastases--usefulness and challenges.